Evidence map›Paper›PMID 18174303›Full record

ArticleJournal of clinical microbiology2008

Rapid identification of mycobacteria by Raman spectroscopy.

P C A M Buijtels, H F M Willemse-Erix, P L C Petit, H P Endtz, G J Puppels, H A Verbrugh, A van Belkum, D van Soolingen, K Maquelin

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Future Research Directions on Mycobacterium tuberculosis Proteins.Advances in experimental medicine and biology · 2026
    Review
  3. Review
  4. Machine learning analysis of SERS fingerprinting for the rapid determination ofComputational and structural biotechnology journal · 2022
    Article
  5. Biofilms of the non-tuberculousCell surface (Amsterdam, Netherlands) · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Discrimination of Aspergillus lentulus from Aspergillus fumigatus by Raman spectroscopy and MALDI-TOF MS.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2014
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

P C A M BuijtelsUniversity Medical Centre Utrecht, Department of Medical Microbiology, HP G04.614, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. P.Buijtels@umcutrecht.nl
H F M Willemse-Erix
P L C Petit
H P Endtz
G J Puppels
H A Verbrugh
A van Belkum
D van Soolingen
K Maquelin

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A number of rapid identification methods have been developed to improve the accuracy for diagnosis of tuberculosis and to speed up the presumptive identification of Mycobacterium species. Most of these methods have been validated for a limited group of microorganisms only. Here, Raman spectroscopy was compared to 16S rRNA sequencing for the identification of Mycobacterium tuberculosis complex strains and the most frequently found strains of nontuberculous mycobacteria (NTM). A total of 63 strains, belonging to eight distinct species, were analyzed. The sensitivity of Raman spectroscopy for the identification of Mycobacterium species was 95.2%. All M. tuberculosis strains were correctly identified (7 of 7; 100%), as were 54 of 57 NTM strains (94%). The differentiation between M. tuberculosis and NTM was invariably correct for all strains. Moreover, the reproducibility of Raman spectroscopy was evaluated for killed mycobacteria (by heat and formalin) versus viable mycobacteria. The spectra of the heat-inactivated bacteria showed minimal differences compared to the spectra of viable mycobacteria. Therefore, the identification of mycobacteria appears possible without biosafety level 3 precautions. Raman spectroscopy provides a novel answer to the need for rapid species identification of cultured mycobacteria in a clinical diagnostic setting.

Indexed as

Hot TemperatureHumansMycobacteriumMycobacterium InfectionsMycobacterium tuberculosisReproducibility of ResultsRNA, Ribosomal, 16SSensitivity and SpecificitySequence Analysis, DNASpecies SpecificitySpectrum Analysis, RamanTime FactorsTuberculosisRNA, Ribosomal, 16S

Identifiers

PMID18174303
PMCPMC2268361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.